RE: Ana18 Mar 2019 08:44
vandan.s wise words reflect any speculative stock especially AIM / NEX
Regards Ananda,s chances of delivering share holder value is a matter of one,s own dd, Personally I am satisfied with the CEO/BOD integrity and caliber, ANA,s investments in iCAN & LHT are imo excellent and shrewd choices , as van states the hapac story has the potential to be a dud, However the Management team behind hapac are savvy,highly experienced in marketing products in this sector,The upside to hapac being a European & Global success is astronomical , ANA hold 15% of LHT with option to increase that wedge, iCAN is an Israeli Medical Cannabis play with similar traits to the uk,s European Cannabis Holdings with conference management etc tentacles into the US and south America aswel as the UK through Ananda , The highly speculative plays emerging now in this space are a year behind ANA & SATI and are prone to have missed the boat as the sector is saturated now never mind come Q3 19
SATI are a different prospect to Ananda in the sense they are seed to product management ,where Ananda is an investment vehicle in what looks like to be strong future [plays